Despite a small number of tumors with PIK3CA mutations in our cohort, we found that PIK3CA mutations largely overlapped with KRAS mutations, which was consistent with the previous studies in European [20] and Japanese [21] CRC patients with metastasis. This evidence concerns the gene KRAS and colorectal carcinoma.